Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus

Arthritis and Rheumatism

Volumn 63, Issue 12, 2011, Pages 3801-3806

  Giardina, Emiliano ^a,b   Hüffmeier, Ulrike ^c   Ravindran, Jaya ^d   Behrens, Frank ^e   Lepre, Tiziana ^a,b   McHugh, Neil J ^d   Korendowych, Eleanor ^d   Burkhardt, Harald ^e   Novelli, Giuseppe ^a,b,f   Reis, André ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF BATH   (United Kingdom)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f Responsable for National Scientific Habilitation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; TUMOR NECROSIS FACTOR;

ALLELE; ARTICLE; CHROMOSOME 6P; CONTROLLED STUDY; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE PSORS1; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; GREAT BRITAIN; HLA-C ANTIGENS; HUMANS; ITALY; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82455210508     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30591     Document Type: Article

References (15)

1. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P,. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis 2005; 64: 14-7.
2. Rahman P, O'Rielly DD,. Psoriatic arthritis: genetic susceptibility and pharmacogenetics. Pharmacogenomics 2008; 9: 195-205. (Pubitemid 351566943)
3. Moll JM, Wright V,. Familial occurrence of psoriatic arthritis. Ann Rheum Dis 1973; 32: 181-201.
4. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006; 78: 827-51.
5. Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P,. Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol 2008; 35: 1449-53. (Pubitemid 352000802)
6. Mossner R, Kingo K, Kleensang A, Krüger U, Konig IR, Silm H, et al. Association of TNF -238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol 2005; 124: 282-4. (Pubitemid 40100984)
7. Van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP,. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 2006; 65: 1551-7. (Pubitemid 44799664)
8. Reich K, Huffmeier U, Konig IR, Lascorz J, Lohmann J, Wendler J, et al. TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele. Arthritis Rheum 2007; 56: 2056-64. (Pubitemid 47110405)
9. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73. (Pubitemid 44205029)
10. Huffmeier U, Lascorz J, Bohm B, Lohmann J, Wendler J, Mössner R, et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol 2009; 129: 355-8.
11. De Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006; 38: 1166-72. (Pubitemid 44470362)
12. Bunce M, Barnardo MC, Welsh KI,. Improvements in HLA-C typing using sequence-specific primers (PCR-SSP) including definition of HLA-Cw9 and Cw10 and a new allele HLA-"Cw7/8v". Tissue Antigens 1994; 44: 200-3. (Pubitemid 24298090)
13. McHugh NJ, Owen P, Cox B, Dunphy J, Welsh K,. MHC class II, tumour necrosis factor α, and lymphotoxin α gene haplotype associations with serological subsets of systemic lupus erythematosus. Ann Rheum Dis 2006; 65: 488-94.
14. Lv K, Chen R, Cai Q, Fang M, Sun S,. Effects of a single nucleotide polymorphism on the expression of human tumour necrosis factor-α. Scand J Immunol 2006; 64: 164-9. (Pubitemid 44034321)
15. Kang CP, Lee KW, Yoo DH, Kang C, Bae SC,. The influence of a polymorphism at position -857 of the tumour necrosis factor α gene on clinical response to etanercept therapy in rheumatoid arthritis. Rheumatology (Oxford) 2005; 44: 547-52. (Pubitemid 41511149)